nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—CYP1A2—chronic obstructive pulmonary disease	0.453	1	CbGaD
Domperidone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.049	0.132	CbGbCtD
Domperidone—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0425	0.115	CbGbCtD
Domperidone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0412	0.111	CbGbCtD
Domperidone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0412	0.111	CbGbCtD
Domperidone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0367	0.0989	CbGbCtD
Domperidone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0346	0.0931	CbGbCtD
Domperidone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0234	0.0629	CbGbCtD
Domperidone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0223	0.06	CbGbCtD
Domperidone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0199	0.0535	CbGbCtD
Domperidone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0194	0.0524	CbGbCtD
Domperidone—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0184	0.0495	CbGbCtD
Domperidone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0117	0.0314	CbGbCtD
Domperidone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.011	0.0296	CbGbCtD
Domperidone—Abdominal cramps—Aminophylline—chronic obstructive pulmonary disease	0.00292	0.0258	CcSEcCtD
Domperidone—Heartburn—Aminophylline—chronic obstructive pulmonary disease	0.00287	0.0253	CcSEcCtD
Domperidone—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.00265	0.0234	CcSEcCtD
Domperidone—Heartburn—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.0182	CcSEcCtD
Domperidone—Breast pain—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.0143	CcSEcCtD
Domperidone—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.0016	0.0141	CcSEcCtD
Domperidone—Menstruation irregular—Prednisolone—chronic obstructive pulmonary disease	0.00147	0.013	CcSEcCtD
Domperidone—Cramps of lower extremities—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.0122	CcSEcCtD
Domperidone—Cramps of lower extremities—Formoterol—chronic obstructive pulmonary disease	0.00138	0.0122	CcSEcCtD
Domperidone—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00137	0.0121	CcSEcCtD
Domperidone—Cramps of lower extremities—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.0115	CcSEcCtD
Domperidone—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.0112	CcSEcCtD
Domperidone—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.0111	CcSEcCtD
Domperidone—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00124	0.011	CcSEcCtD
Domperidone—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.00119	0.0105	CcSEcCtD
Domperidone—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00114	0.0101	CcSEcCtD
Domperidone—Thirst—Montelukast—chronic obstructive pulmonary disease	0.00112	0.0099	CcSEcCtD
Domperidone—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00963	CcSEcCtD
Domperidone—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00942	CcSEcCtD
Domperidone—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00899	CcSEcCtD
Domperidone—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00895	CcSEcCtD
Domperidone—Migraine—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00894	CcSEcCtD
Domperidone—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.000983	0.00867	CcSEcCtD
Domperidone—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000955	0.00842	CcSEcCtD
Domperidone—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00093	0.0082	CcSEcCtD
Domperidone—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000903	0.00796	CcSEcCtD
Domperidone—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000886	0.00781	CcSEcCtD
Domperidone—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000847	0.00747	CcSEcCtD
Domperidone—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000839	0.0074	CcSEcCtD
Domperidone—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000838	0.00739	CcSEcCtD
Domperidone—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000835	0.00736	CcSEcCtD
Domperidone—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000835	0.00736	CcSEcCtD
Domperidone—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.000832	0.00734	CcSEcCtD
Domperidone—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000823	0.00726	CcSEcCtD
Domperidone—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.000817	0.0072	CcSEcCtD
Domperidone—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.000817	0.0072	CcSEcCtD
Domperidone—Droperidol—HTR2A—chronic obstructive pulmonary disease	0.000801	0.144	CrCbGaD
Domperidone—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.0008	0.00706	CcSEcCtD
Domperidone—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000794	0.007	CcSEcCtD
Domperidone—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.000774	0.00682	CcSEcCtD
Domperidone—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.000772	0.0068	CcSEcCtD
Domperidone—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000763	0.00672	CcSEcCtD
Domperidone—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000758	0.00668	CcSEcCtD
Domperidone—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000723	0.00637	CcSEcCtD
Domperidone—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000719	0.00634	CcSEcCtD
Domperidone—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000699	0.00616	CcSEcCtD
Domperidone—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000678	0.00597	CcSEcCtD
Domperidone—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000674	0.00594	CcSEcCtD
Domperidone—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000674	0.00594	CcSEcCtD
Domperidone—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000672	0.00592	CcSEcCtD
Domperidone—Sertindole—SLC6A4—chronic obstructive pulmonary disease	0.000671	0.121	CrCbGaD
Domperidone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000666	0.00587	CcSEcCtD
Domperidone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000665	0.00587	CcSEcCtD
Domperidone—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000664	0.00586	CcSEcCtD
Domperidone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000662	0.00583	CcSEcCtD
Domperidone—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000658	0.0058	CcSEcCtD
Domperidone—Tension—Formoterol—chronic obstructive pulmonary disease	0.000645	0.00568	CcSEcCtD
Domperidone—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000645	0.00568	CcSEcCtD
Domperidone—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000638	0.00562	CcSEcCtD
Domperidone—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000638	0.00562	CcSEcCtD
Domperidone—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000637	0.00562	CcSEcCtD
Domperidone—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000637	0.00561	CcSEcCtD
Domperidone—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000632	0.00557	CcSEcCtD
Domperidone—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000632	0.00557	CcSEcCtD
Domperidone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000627	0.00553	CcSEcCtD
Domperidone—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00062	0.00547	CcSEcCtD
Domperidone—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000619	0.00545	CcSEcCtD
Domperidone—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.00537	CcSEcCtD
Domperidone—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000602	0.00531	CcSEcCtD
Domperidone—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000601	0.0053	CcSEcCtD
Domperidone—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000596	0.00526	CcSEcCtD
Domperidone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000585	0.00516	CcSEcCtD
Domperidone—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000581	0.00512	CcSEcCtD
Domperidone—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000581	0.00512	CcSEcCtD
Domperidone—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000569	0.00501	CcSEcCtD
Domperidone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000568	0.00501	CcSEcCtD
Domperidone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00056	0.00493	CcSEcCtD
Domperidone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000557	0.00491	CcSEcCtD
Domperidone—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00483	CcSEcCtD
Domperidone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000547	0.00482	CcSEcCtD
Domperidone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000547	0.00482	CcSEcCtD
Domperidone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000536	0.00473	CcSEcCtD
Domperidone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000536	0.00473	CcSEcCtD
Domperidone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000528	0.00465	CcSEcCtD
Domperidone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000525	0.00463	CcSEcCtD
Domperidone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000525	0.00463	CcSEcCtD
Domperidone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000516	0.00455	CcSEcCtD
Domperidone—Sertindole—HTR2A—chronic obstructive pulmonary disease	0.000516	0.0929	CrCbGaD
Domperidone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.00446	CcSEcCtD
Domperidone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000501	0.00442	CcSEcCtD
Domperidone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000501	0.00442	CcSEcCtD
Domperidone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000498	0.00439	CcSEcCtD
Domperidone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000485	0.00427	CcSEcCtD
Domperidone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000485	0.00427	CcSEcCtD
Domperidone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000482	0.00425	CcSEcCtD
Domperidone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000477	0.0042	CcSEcCtD
Domperidone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.0042	CcSEcCtD
Domperidone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000475	0.00419	CcSEcCtD
Domperidone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000473	0.00417	CcSEcCtD
Domperidone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000472	0.00416	CcSEcCtD
Domperidone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000472	0.00416	CcSEcCtD
Domperidone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00047	0.00414	CcSEcCtD
Domperidone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00412	CcSEcCtD
Domperidone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000466	0.00411	CcSEcCtD
Domperidone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000462	0.00408	CcSEcCtD
Domperidone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000458	0.00404	CcSEcCtD
Domperidone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000458	0.00404	CcSEcCtD
Domperidone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00404	CcSEcCtD
Domperidone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00397	CcSEcCtD
Domperidone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000448	0.00395	CcSEcCtD
Domperidone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000446	0.00393	CcSEcCtD
Domperidone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000444	0.00392	CcSEcCtD
Domperidone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000444	0.00391	CcSEcCtD
Domperidone—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000443	0.0039	CcSEcCtD
Domperidone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000441	0.00389	CcSEcCtD
Domperidone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000439	0.00387	CcSEcCtD
Domperidone—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000438	0.00386	CcSEcCtD
Domperidone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.00382	CcSEcCtD
Domperidone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000426	0.00375	CcSEcCtD
Domperidone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000426	0.00375	CcSEcCtD
Domperidone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000424	0.00374	CcSEcCtD
Domperidone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000424	0.00374	CcSEcCtD
Domperidone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000422	0.00372	CcSEcCtD
Domperidone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000419	0.00369	CcSEcCtD
Domperidone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000418	0.00369	CcSEcCtD
Domperidone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000418	0.00369	CcSEcCtD
Domperidone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000417	0.00368	CcSEcCtD
Domperidone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000416	0.00367	CcSEcCtD
Domperidone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000415	0.00366	CcSEcCtD
Domperidone—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00041	0.00361	CcSEcCtD
Domperidone—Nefazodone—SLC6A4—chronic obstructive pulmonary disease	0.000407	0.0732	CrCbGaD
Domperidone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000402	0.00355	CcSEcCtD
Domperidone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.00353	CcSEcCtD
Domperidone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000395	0.00348	CcSEcCtD
Domperidone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00339	CcSEcCtD
Domperidone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00339	CcSEcCtD
Domperidone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.00334	CcSEcCtD
Domperidone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000379	0.00334	CcSEcCtD
Domperidone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00332	CcSEcCtD
Domperidone—Trazodone—SLC6A4—chronic obstructive pulmonary disease	0.000376	0.0677	CrCbGaD
Domperidone—Pimozide—CYP1A2—chronic obstructive pulmonary disease	0.000373	0.067	CrCbGaD
Domperidone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000372	0.00328	CcSEcCtD
Domperidone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000367	0.00323	CcSEcCtD
Domperidone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000367	0.00323	CcSEcCtD
Domperidone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.00322	CcSEcCtD
Domperidone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.0032	CcSEcCtD
Domperidone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000359	0.00317	CcSEcCtD
Domperidone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00316	CcSEcCtD
Domperidone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000355	0.00313	CcSEcCtD
Domperidone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000355	0.00313	CcSEcCtD
Domperidone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000347	0.00306	CcSEcCtD
Domperidone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00305	CcSEcCtD
Domperidone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.00301	CcSEcCtD
Domperidone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000341	0.00301	CcSEcCtD
Domperidone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000338	0.00298	CcSEcCtD
Domperidone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000338	0.00298	CcSEcCtD
Domperidone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000338	0.00298	CcSEcCtD
Domperidone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000338	0.00298	CcSEcCtD
Domperidone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00296	CcSEcCtD
Domperidone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00296	CcSEcCtD
Domperidone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.00295	CcSEcCtD
Domperidone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000334	0.00294	CcSEcCtD
Domperidone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000331	0.00292	CcSEcCtD
Domperidone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000331	0.00292	CcSEcCtD
Domperidone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000329	0.0029	CcSEcCtD
Domperidone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.00284	CcSEcCtD
Domperidone—Pipotiazine—CYP1A2—chronic obstructive pulmonary disease	0.000321	0.0578	CrCbGaD
Domperidone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000319	0.00281	CcSEcCtD
Domperidone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000319	0.00281	CcSEcCtD
Domperidone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000318	0.00281	CcSEcCtD
Domperidone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.00281	CcSEcCtD
Domperidone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.0028	CcSEcCtD
Domperidone—Zuclopenthixol—HTR2A—chronic obstructive pulmonary disease	0.000314	0.0566	CrCbGaD
Domperidone—Pimozide—HTR2A—chronic obstructive pulmonary disease	0.000314	0.0566	CrCbGaD
Domperidone—Nefazodone—HTR2A—chronic obstructive pulmonary disease	0.000313	0.0563	CrCbGaD
Domperidone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000312	0.00275	CcSEcCtD
Domperidone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.00265	CcSEcCtD
Domperidone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.00256	CcSEcCtD
Domperidone—Trazodone—HTR2A—chronic obstructive pulmonary disease	0.000289	0.0521	CrCbGaD
Domperidone—Pipotiazine—HTR2A—chronic obstructive pulmonary disease	0.000271	0.0488	CrCbGaD
Domperidone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00234	CcSEcCtD
Domperidone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.00232	CcSEcCtD
Domperidone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.00203	CcSEcCtD
Domperidone—Perphenazine—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.0395	CrCbGaD
Domperidone—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00186	CcSEcCtD
Domperidone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.00169	CcSEcCtD
Domperidone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00168	CcSEcCtD
Domperidone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00164	CcSEcCtD
Domperidone—Pipotiazine—ALB—chronic obstructive pulmonary disease	0.000185	0.0334	CrCbGaD
Domperidone—Perphenazine—HTR2A—chronic obstructive pulmonary disease	0.000185	0.0333	CrCbGaD
Domperidone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.00161	CcSEcCtD
Domperidone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.00161	CcSEcCtD
Domperidone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.0016	CcSEcCtD
Domperidone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00159	CcSEcCtD
Domperidone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00152	CcSEcCtD
Domperidone—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00148	CcSEcCtD
Domperidone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00147	CcSEcCtD
Domperidone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00133	CcSEcCtD
Domperidone—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00132	CcSEcCtD
Domperidone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00127	CcSEcCtD
Domperidone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00123	CcSEcCtD
Domperidone—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00118	CcSEcCtD
Domperidone—Rash—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00117	CcSEcCtD
Domperidone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00117	CcSEcCtD
Domperidone—Headache—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00117	CcSEcCtD
Domperidone—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000125	0.0011	CcSEcCtD
Domperidone—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.87e-05	0.00103	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.84e-05	0.00102	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.84e-05	0.00102	CbGpPWpGaD
Domperidone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.7e-05	0.000997	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	5.67e-05	0.000992	CbGpPWpGaD
Domperidone—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.64e-05	0.000987	CbGpPWpGaD
Domperidone—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.56e-05	0.000974	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	5.36e-05	0.000938	CbGpPWpGaD
Domperidone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	5.36e-05	0.000938	CbGpPWpGaD
Domperidone—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.32e-05	0.00093	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.28e-05	0.000924	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.28e-05	0.000924	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.27e-05	0.000921	CbGpPWpGaD
Domperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	5.25e-05	0.000918	CbGpPWpGaD
Domperidone—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.24e-05	0.000917	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	5.24e-05	0.000917	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.22e-05	0.000914	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.07e-05	0.000887	CbGpPWpGaD
Domperidone—KCNH2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.05e-05	0.000884	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.01e-05	0.000877	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5e-05	0.000875	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.96e-05	0.000867	CbGpPWpGaD
Domperidone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	4.95e-05	0.000867	CbGpPWpGaD
Domperidone—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.89e-05	0.000855	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.85e-05	0.000848	CbGpPWpGaD
Domperidone—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.82e-05	0.000843	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.8e-05	0.00084	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.78e-05	0.000837	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	4.77e-05	0.000835	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.75e-05	0.000831	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.75e-05	0.000831	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	4.67e-05	0.000817	CbGpPWpGaD
Domperidone—DRD3—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.66e-05	0.000816	CbGpPWpGaD
Domperidone—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.63e-05	0.00081	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.62e-05	0.000809	CbGpPWpGaD
Domperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.59e-05	0.000803	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.57e-05	0.0008	CbGpPWpGaD
Domperidone—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.57e-05	0.000799	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.57e-05	0.000799	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.54e-05	0.000794	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	4.54e-05	0.000794	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.52e-05	0.000792	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.52e-05	0.000792	CbGpPWpGaD
Domperidone—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.5e-05	0.000788	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.47e-05	0.000783	CbGpPWpGaD
Domperidone—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.44e-05	0.000777	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.34e-05	0.00076	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.29e-05	0.000751	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.17e-05	0.000729	CbGpPWpGaD
Domperidone—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.14e-05	0.000724	CbGpPWpGaD
Domperidone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.11e-05	0.000719	CbGpPWpGaD
Domperidone—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.08e-05	0.000714	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.03e-05	0.000705	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4e-05	0.000699	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.95e-05	0.000692	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.94e-05	0.000689	CbGpPWpGaD
Domperidone—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.92e-05	0.000687	CbGpPWpGaD
Domperidone—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.87e-05	0.000677	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.73e-05	0.000652	CbGpPWpGaD
Domperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.71e-05	0.000649	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.68e-05	0.000643	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.66e-05	0.00064	CbGpPWpGaD
Domperidone—DRD2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.57e-05	0.000624	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.55e-05	0.000621	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.54e-05	0.000619	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.5e-05	0.000613	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.5e-05	0.000612	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.48e-05	0.000608	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.47e-05	0.000607	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	3.45e-05	0.000604	CbGpPWpGaD
Domperidone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.43e-05	0.0006	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.38e-05	0.000591	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.3e-05	0.000578	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.24e-05	0.000567	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.24e-05	0.000566	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.21e-05	0.000562	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.19e-05	0.000559	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.16e-05	0.000552	CbGpPWpGaD
Domperidone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.15e-05	0.000551	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.14e-05	0.000549	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.03e-05	0.00053	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.01e-05	0.000526	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3e-05	0.000525	CbGpPWpGaD
Domperidone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.99e-05	0.000523	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.98e-05	0.000522	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.97e-05	0.000519	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.95e-05	0.000516	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.92e-05	0.000512	CbGpPWpGaD
Domperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.84e-05	0.000496	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.82e-05	0.000494	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.82e-05	0.000494	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.72e-05	0.000476	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.68e-05	0.000469	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.68e-05	0.000469	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.62e-05	0.000458	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.58e-05	0.000452	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.55e-05	0.000447	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.55e-05	0.000446	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.53e-05	0.000442	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.52e-05	0.000441	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.48e-05	0.000434	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.47e-05	0.000432	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.44e-05	0.000426	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.4e-05	0.00042	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.37e-05	0.000414	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.34e-05	0.00041	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.3e-05	0.000403	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.3e-05	0.000402	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.27e-05	0.000397	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.26e-05	0.000395	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.25e-05	0.000394	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.23e-05	0.000391	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.17e-05	0.000379	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.16e-05	0.000378	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.16e-05	0.000378	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.12e-05	0.000371	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.12e-05	0.00037	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.09e-05	0.000366	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.07e-05	0.000361	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.05e-05	0.000359	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.03e-05	0.000356	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.03e-05	0.000355	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.98e-05	0.000346	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.94e-05	0.00034	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.92e-05	0.000336	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.91e-05	0.000333	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.89e-05	0.000331	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.89e-05	0.00033	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.87e-05	0.000326	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.84e-05	0.000323	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.82e-05	0.000319	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.81e-05	0.000317	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.79e-05	0.000314	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.77e-05	0.00031	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.77e-05	0.00031	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.74e-05	0.000305	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.7e-05	0.000298	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.66e-05	0.000291	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.63e-05	0.000284	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.61e-05	0.000282	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.6e-05	0.00028	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.6e-05	0.00028	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.6e-05	0.000279	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.58e-05	0.000277	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.58e-05	0.000277	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.58e-05	0.000276	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.57e-05	0.000275	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.57e-05	0.000274	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.54e-05	0.00027	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.53e-05	0.000268	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.51e-05	0.000264	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.47e-05	0.000258	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.47e-05	0.000257	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.46e-05	0.000255	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.45e-05	0.000253	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.44e-05	0.000252	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.44e-05	0.000252	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.39e-05	0.000244	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.39e-05	0.000242	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.38e-05	0.000241	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.36e-05	0.000237	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.33e-05	0.000232	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.31e-05	0.00023	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.31e-05	0.000229	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.3e-05	0.000227	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.29e-05	0.000226	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.29e-05	0.000225	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.28e-05	0.000224	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.26e-05	0.000221	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.26e-05	0.00022	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.22e-05	0.000214	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.22e-05	0.000213	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.21e-05	0.000212	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.2e-05	0.00021	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.18e-05	0.000207	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.17e-05	0.000206	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.16e-05	0.000202	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.000199	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	0.000195	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.11e-05	0.000194	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.11e-05	0.000194	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	0.000194	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.1e-05	0.000193	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.1e-05	0.000192	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.000191	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.09e-05	0.000191	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.06e-05	0.000185	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.06e-05	0.000185	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.05e-05	0.000183	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000179	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000178	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.01e-05	0.000177	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1e-05	0.000175	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1e-05	0.000175	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.85e-06	0.000172	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.65e-06	0.000169	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.65e-06	0.000169	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.65e-06	0.000169	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.52e-06	0.000166	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.09e-06	0.000159	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.97e-06	0.000157	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.87e-06	0.000155	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.58e-06	0.00015	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.56e-06	0.00015	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.48e-06	0.000148	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.41e-06	0.000147	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.36e-06	0.000146	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.14e-06	0.000142	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.1e-06	0.000142	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.92e-06	0.000139	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	7.75e-06	0.000136	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.74e-06	0.000135	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.74e-06	0.000135	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.73e-06	0.000135	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.7e-06	0.000135	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.6e-06	0.000133	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	7.57e-06	0.000132	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.41e-06	0.00013	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.38e-06	0.000129	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	7.24e-06	0.000127	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.13e-06	0.000125	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.08e-06	0.000124	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.95e-06	0.000122	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.71e-06	0.000117	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	6.56e-06	0.000115	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.55e-06	0.000115	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.38e-06	0.000112	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	6.27e-06	0.00011	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.25e-06	0.000109	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.23e-06	0.000109	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.94e-06	0.000104	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.92e-06	0.000104	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.86e-06	0.000103	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.71e-06	0.0001	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.47e-06	9.56e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.46e-06	9.56e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.38e-06	9.42e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.32e-06	9.31e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.25e-06	9.19e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.18e-06	9.06e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.15e-06	9.01e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.88e-06	8.54e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.81e-06	8.41e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.79e-06	8.37e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.56e-06	7.98e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.36e-06	7.63e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.02e-06	7.03e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.68e-06	6.44e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.52e-06	6.16e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.37e-06	5.89e-05	CbGpPWpGaD
